Dopamine D2 receptor blockade in vivo with the novel antipsychotics risperidone and remoxipride--an 123I-IBZM single photon emission tomography (SPET) study. [electronic resource]
Producer: 19950525Description: 55-61 p. digitalISSN:- 0033-3158
- Adult
- Antipsychotic Agents -- pharmacology
- Basal Ganglia -- metabolism
- Benzamides
- Cerebral Cortex -- metabolism
- Dopamine D2 Receptor Antagonists
- Female
- Humans
- Image Processing, Computer-Assisted
- Iodine Radioisotopes
- Isoxazoles -- pharmacology
- Male
- Middle Aged
- Neostriatum -- anatomy & histology
- Piperidines -- pharmacology
- Psychiatric Status Rating Scales
- Psychotic Disorders -- drug therapy
- Pyrrolidines
- Remoxipride -- pharmacology
- Risperidone
- Schizophrenia -- drug therapy
- Tomography, Emission-Computed, Single-Photon
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.